Hsbc Holdings PLC Tg Therapeutics, Inc. Call Options Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $103,260 - $151,680	6,000 Added 20.0%	36,000 $842,000
Q2 2024 Aug 12, 2024	SELL	$13.32 - $19.19 $119,880 - $172,710	-9,000 Reduced 23.08%	30,000 $533,000
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $227,850 - $372,750	17,500 Added 81.4%	39,000 $593,000
Q4 2023 Feb 12, 2024	BUY	$6.68 - $18.81 $143,620 - $404,415	21,500 New	21,500 $367,000
Q2 2023 Aug 11, 2023	BUY	$15.48 - $35.0 $301,860 - $682,500	19,500 Added 144.44%	33,000 $819,000
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $138,105 - $261,090	13,500 New	13,500 $203,000
Q2 2022 Aug 11, 2022	SELL	$3.74 - $10.66 $7,480 - $21,320	-2,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $15,620 - $40,900	2,000 New	2,000 $19,000
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $103,360 - $241,468	-6,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $100,188 - $186,070	4,600 Added 209.09%	6,800 $226,000
Q2 2021 Aug 13, 2021	SELL	$32.5 - $48.96 $620,750 - $935,136	-19,100 Reduced 89.67%	2,200 $85,000
Q1 2021 May 14, 2021	SELL	$41.61 - $54.3 $1.99 Million - $2.6 Million	-47,900 Reduced 69.22%	21,300 $1.03 Million
Q4 2020 Feb 25, 2021	BUY	$25.27 - $54.9 $712,614 - $1.55 Million	28,200 Added 68.78%	69,200 $3.6 Million
Q3 2020 Nov 12, 2020	BUY	$18.49 - $27.24 $203,389 - $299,640	11,000 Added 36.67%	41,000 $1.1 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $267,000 - $655,200	30,000 New	30,000 $584,000
Q1 2020 May 15, 2020	SELL	$7.14 - $15.99 $699,720 - $1.57 Million	-98,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $382,500 - $840,000	75,000 Added 326.09%	98,000 $1.07 Million
Q3 2019 Nov 14, 2019	BUY	$5.38 - $8.99 $12,912 - $21,576	2,400 Added 11.65%	23,000 $129,000
Q2 2019 Aug 13, 2019	BUY	$6.27 - $8.65 $3,761 - $5,190	600 Added 3.0%	20,600 $178,000
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $80,399 - $160,799	20,000 New	20,000 $161,000
Q4 2018 Feb 13, 2019	SELL	$3.44 - $5.76 $107,672 - $180,288	-31,300 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.15 - $14.0 $5,150 - $14,000	1,000 Added 3.3%	31,300 $175,000
Q2 2018 Aug 10, 2018	BUY	$12.5 - $15.0 $378,750 - $454,500	30,300 New	30,300 $398,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$475 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$351 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$281 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$111 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$98.9 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.48B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account